Clinical trial
Fluticasone Nasal Spray Patient Preference Study
NCT00398476 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00398476 |
|---|---|
| Title | Fluticasone Nasal Spray Patient Preference Study |
| Official title | A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Fluticasone Propionate Aqueous Nasal Spray in Subject With Allergic Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | fluticasone propionate (FP), fluticasone furoate (FF) |
| Enrollment | 127 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 4, 2006 |
| Completion | Dec 4, 2006 |
| First posted | Nov 10, 2006 |
| Last update posted | Mar 1, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: